Differences in antigenicity of E2 in Semliki Forest virus particles and in infected cells
- PMID: 7526823
- PMCID: PMC7086913
- DOI: 10.1007/BF01310027
Differences in antigenicity of E2 in Semliki Forest virus particles and in infected cells
Abstract
Using six monoclonal antibodies to epitopes a-f on the glycoprotein E2 of Semliki Forest virus (SFV) we found antigenic differences between E2 in infected cells and in virus particles, respectively, if glycosylation was impaired by 2-deoxy-D-glucose or inhibited by N-methyl-1-deoxynojirimycin. Furthermore we concluded that a conformational change of E2 takes place on virus budding.
References
-
- Fenouillet E, Gluckman JC. Effect of a glucosidase inhibitor on the bioactivity and immunoreactivity of human immunodeficiency virus type 1 envelope glycoprotein. J Gen Virol. 1991;72:1919–1926. - PubMed
-
- Kaluza G, Scholtissek C, Rott R. Inhibition of the multiplication of enveloped RNA-viruses by glucosamine and 2-deoxy-D-glucose. J Gen Virol. 1972;14:251–259. - PubMed
-
- Kaluza G, Rott R, Schwarz RT. Carbohydrate-induced conformational changes of Semliki Forest virus glycoproteins determine antigenicity. Virology. 1980;102:286–299. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources